Has Yousif Ahmad, MD received payments from drug or device companies?

Yes. Drug and device makers reported $205,045 in general payments to Yousif Ahmad, MD across 437 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Yousif Ahmad, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Yousif Ahmad, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Yousif Ahmad, MD

Interventional Cardiology · San Francisco, CANPI 1447716725

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (37.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Shockwave Medical, Inc at 59.1% of the total. 2025 is the largest year on record at $120,865, more than ten times the $1,124 reported in 2020. Among interventional cardiology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$205,045in general payments, 2019–2025

Across 437 payments — averaging $469.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Shockwave Medical, Inc$121K
Boston Scientific$52K
Edwards Lifesciences$9K
Abiomed$8K
Medtronic$5K
Cardiovascular Systems Inc.$4K
plus $6K from 9 others

$175,354in research payments, 2019–2025

Across 19 payments — averaging $9229.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Shockwave Medical, Inc$175K

What the payments were for

Consulting fees$77,48838%
Speaking & faculty fees$73,62536%
Travel & lodging$31,80416%
Food & beverage$22,12811%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Shockwave Medical, Inc	54	$121,127
Boston Scientific	99	$52,145
Edwards Lifesciences	185	$8,782
Abiomed	16	$7,734
Medtronic	49	$4,878
Cardiovascular Systems Inc.	5	$4,358
Penumbra, Inc.	8	$4,220
Ancora Heart, Inc.	2	$379
Abbott	4	$345
Philips North America LLC	5	$325
Teleflex LLC	5	$311
Opsens Inc.	1	$196
Amgen	1	$124
Biotronik Inc.	2	$109
W. L. Gore & Associates, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$120,683
GENERAL VASCULAR ACCESS$18,941
GENERAL BALLOONS$7,678
Diamondback Coronary$4,433
Indigo System$4,090
General - CT_IC$3,750
RESOLUTE ONYX$2,848
SAPIEN 3 Ultra RESILIA$2,332
GENERAL - THERAPIES$2,223
AVVIGO Guidance System$1,335
Edwards SAPIEN 3 Transcatheter Heart Valve$919
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$713
COREVALVE EVOLUT R$455
AccuCinch$316
OptoWire$196
TRICLIP$179
STINGRAY$170
SYMPLICITY G3$158
CoreValve Evolut$150
TURNPIKE$146

How this compares

$205,045 in reported general payments places this provider in the 90th percentile of 585 interventional cardiology providers in California.

See all interventional cardiology providers in California →

Medicare billing

Part B allowed, 2024

$117,817

Medicare patients

187

Services billed

615

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	31	$165

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in San Francisco

Bao TranSan Francisco$130K
Sammy ElmariahSan Francisco$126K
Matthew Pricela Jolla$2.3M
Frederick St GoarMountain View$2.2M
Saibal KarThousand Oaks$1.1M
Rahul SharmaStanford$1M
Puneet KhannaRancho Mirage$1M
Dennis SheehanRedwood City$900K
Suhail DohadBeverly Hills$802K
Curtiss Stinisla Jolla$759K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →